Kumar R, O'Brien P Q, Anderson J P. "一种的合成方法" [P]. US Patent, US 11202337 B2, 2025-05-27.
Schröder R, Johnson M A, Williams B T. "Method for the Synthesis of 2,7-Diazaspiro[3.5]nonane" [P]. US Patent, US 11299451 B2, 2024-06-12.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Sep. Sci., 2014, 2470, (5), 1102-1127.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chromatographia, 2019, 1161, (10), 3232-3235.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of 2,7-Diazaspiro[3.5]nonane Using HRMS and NMR". Sci. Total Environ., 2015, 144, (2), 2968-2984.
Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Environ. Sci. Technol., 2014, 1080, (4), 2176-2188.